Stellar Biotechnologies to Present at 6th Annual LD Micro Conference December 4, 2013
25 November 2013 - 3:05PM
Marketwired
Stellar Biotechnologies to Present at 6th Annual LD Micro
Conference December 4, 2013
PORT HUENEME, CA--(Marketwired - Nov 25, 2013) - Stellar
Biotechnologies, Inc. ("Stellar" or "the Company") (OTCQB: SBOTF)
(TSX-VENTURE: KLH), the world leader in sustainable manufacture of
Keyhole Limpet Hemocyanin (KLH), announced today that the Company's
President and CEO Frank Oakes will present at the Sixth Annual LD
Micro Conference to be held at the Luxe Sunset Boulevard Hotel in
Los Angeles, on December 4, 2013 at 8:00 am PT.
Mr. Oakes will provide an update on the Company's Stellar KLH™
technology, recent accomplishments, and 2014 objectives. His
presentation will be followed by a breakout Q&A
session. Additional members of Stellar's executive team will
attend and be available to discuss the Company's programs over the
3-day event.
Please contact the LD Micro Conference organizers to attend the
event at www.ldmicro.com, or Mark McPartland with Stellar
Biotechnologies at markmcp@stellarbiotech.com to arrange a meeting
with Stellar's management.
Stellar Biotechnologies' presentation details: Date: December 4,
2013 Time: 8:00 am PT Location: The Luxe Sunset Boulevard Hotel,
Los Angeles - Track 2
The presentation will be available on the Stellar
Biotechnologies website following the event at
http://stellarbiotechnologies.com/investors/profile_presentations/
About LD MICRO LD MICRO is a by-invitation only newsletter firm
that focuses on finding undervalued companies in the micro-cap
space. Since 2002, the firm has published an annual list of
recommended stocks as well as comprehensive reports on select
companies throughout the year. LD MICRO concentrates on finding,
researching, and investing in companies that are overlooked by
institutional investors. It is a non-registered investment advisor.
If you are a private or institutional investor interested in
learning more about the conference, or wish to attend, please
contact Eric Lahiji (Eric@ldmicro.com).
About Stellar Biotechnologies, Inc. Stellar Biotechnologies,
Inc. (OTCQB: SBOTF) (TSX-VENTURE: KLH) is the world leader in
sustainable manufacture of Keyhole Limpet Hemocyanin (KLH), an
important immune-stimulating protein used in wide-ranging
therapeutic and diagnostic markets. KLH is both an active
pharmaceutical ingredient (API) in many new immunotherapies
(targeting cancer, infectious diseases, and immune disorders) as
well as a finished product for measuring immune status. Stellar
Biotechnologies is unique in its proprietary methods, facilities,
and KLH technology. We are committed to meeting the growing
demand for commercial-scale supplies of GMP grade KLH, ensuring
environmentally sound KLH production, and developing KLH-based
active immunotherapies.
To receive regular updates, enter email at
http://stellarbiotechnologies.com/contact/
Visit www.StellarBiotech.com and the KLH knowledge base
www.KLHSite.com.
Forward Looking Statements There can be no assurance that
forward-looking statements will prove to be accurate, as actual
results and future events could differ materially from those
anticipated in such statements. Readers should not place undue
reliance on such statements. Except in accordance with applicable
securities laws, the Company expressly disclaims any obligation to
update any forward-looking statements or forward-looking statements
that are incorporated by reference herein. This news release does
not constitute an offer to sell, or a solicitation of an offer to
buy any of the Company's securities set out herein in the United
States, or to, or for the benefit or account of, a U.S. Person or
person in the United States. Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in the
policies of the TSX Venture Exchange) accepts responsibility for
the adequacy or accuracy of these releases.
Company Contacts: Frank Oakes President and CEO Phone +1 (805)
488-2800 investorrelations@stellarbiotech.com Mark A. McPartland
Vice President of Corporate Development and Communications Phone:
+1 (805) 488-2800 markmcp@stellarbiotech.com
www.stellarbiotech.com
Stellar Biotechnologies, Inc. (TSXV:KLH)
Historical Stock Chart
Von Dez 2024 bis Jan 2025
Stellar Biotechnologies, Inc. (TSXV:KLH)
Historical Stock Chart
Von Jan 2024 bis Jan 2025
